In previous reports, mice harboring P301L Tau mutation at the ages 5 to 7 months old or before the onset of paralysis and cognitive impairment perform better than the control strains, suggesting that the presence of human Tau could initially improve mice cognition [102, 103]. This evidence concerns the gene MAPT and Cognitive impairment.